Filing Details
HCW Biologics Inc. (NASDAQ:HCWB) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event.
8k filedNASDAQ:HCWB
HCW Biologics Inc. (HCWB) Reports Material Event to SEC
Filing Details HCW Biologics Inc. (NASDAQ:HCWB) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event. Market Context HCW…
Market Context
HCW Biologics Inc.'s stock currently trades at $4.99 with a market capitalization of $4.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for HCW Biologics Inc.'s stock.
All SEC filings for HCW Biologics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HCWB Stock Page
Frequently Asked Questions
Where can I read HCWB's SEC filings?
Browse all filings on our HCWB SEC filings page.
What types of SEC filings does HCW Biologics Inc. file?
Public companies like HCW Biologics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.